Literature DB >> 8614595

Management of the difficult nephrotic patient.

S A Mendoza1, B M Tune.   

Abstract

Most children with nephrotic syndrome do well, usually with multiple relapses and remissions. Some children require high doses of oral steroids to sustain a remission and develop significant steroid toxicity. These patients frequently can be managed with oral alkylating agents or with cyclosporine. A few nephrotic children to not respond to oral prednisone. The most common biopsy finding in steroid-resistant patients is focal segmental glomerulosclerosis. Many patients with this condition progress to chronic renal failure. Evidence suggests that the outcome is improved with either cyclosporine or with a protocol using pulse intravenous methylprednisolone and oral alkylating agents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8614595     DOI: 10.1016/s0031-3955(16)40093-3

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  6 in total

1.  Pulse steroid therapy.

Authors:  Aditi Sinha; Arvind Bagga
Journal:  Indian J Pediatr       Date:  2008-11-21       Impact factor: 1.967

2.  The treatment of relapsing primary nephrotic syndrome in children.

Authors:  Ya-ping Wang; Ai-min Liu; Yu-wen Dai; Cheng Yang; Hong-feng Tang
Journal:  J Zhejiang Univ Sci B       Date:  2005-07       Impact factor: 3.066

3.  Dose- and time-dependent glucocorticoid receptor signaling in podocytes.

Authors:  Adam Guess; Shipra Agrawal; Chang-Ching Wei; Richard F Ransom; Rainer Benndorf; William E Smoyer
Journal:  Am J Physiol Renal Physiol       Date:  2010-07-14

Review 4.  Corticosteroid-resistant nephrotic syndrome with focal and segmental glomerulosclerosis : an update of treatment options for children.

Authors:  Jochen H H Ehrich; Lars Pape; Mario Schiffer
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

5.  Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.

Authors:  Gina-Marie Barletta; William E Smoyer; Timothy E Bunchman; Joseph T Flynn; David B Kershaw
Journal:  Pediatr Nephrol       Date:  2003-05-28       Impact factor: 3.714

Review 6.  Permeability factors in nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  Virginia J Savin; Ellen T McCarthy; Mukut Sharma
Journal:  Kidney Res Clin Pract       Date:  2012-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.